BioAdaptives Announces New Trial Showing PrimiCell® Improved Muscle Repair by over 56%

LAS VEGAS, Dec. 7, 2014 /PRNewswire/ — BioAdaptives, Inc. (BDPT) announced results of the recently completed in vivo trial showing the efficacy of its PrimiCell® product on muscle repair. In the study mice were put into groups, PrimiCell® and the control group. The PrimiCell® group was given PrimiCell® for seven days prior to the treatment. Both …

BioAdaptives Announces New Trial Showing PrimiCell® Improved Muscle Repair by over 56% Read More »

BioAdaptives Announces First Product to Market

LAS VEGAS, Aug. 4, 2014 /PRNewswire via COMTEX/ –– BioAdaptives, Inc. (OTCBB:BDPT) announced results of the clinical trial completed on “PRIMICELL(TM)” which resulted in the research and development of 8 new products. PRIMICELL(TM) is a trademarked name of the first product BioAdaptives, Inc. will bring to market through private labeling and exclusive licensing agreements worldwide. BioAdaptives, Inc. Chairman …

BioAdaptives Announces First Product to Market Read More »

BioAdaptives Equine Development Success and Advisory Board Addition

LAS VEGAS, July 17, 2014 /PRNewswire via COMTEX/ — BioAdaptives, Inc. (OTCBB:BDPT) is pleased to announce Dr. Charlie Timmerman, DVM has joined the Advisory Board for its equine products. Dr. Timmerman is a 1970 graduate of University of Georgia. He has practiced in Aiken, South Carolina since graduating and opened the Aiken Veterinary clinic in 1972. BioAdaptives, under …

BioAdaptives Equine Development Success and Advisory Board Addition Read More »

BioAdaptives Prepares For The Next Step

LAS VEGAS, July 14, 2014 /PRNewswire via COMTEX/ — BioAdaptives, Inc. (OTCBB:BDPT) is pleased to announce Mr. Barry Epling, Chairman has assumed the roles of President and CEO of the Company. Mr. Epling is the owner of Ferris Holding, Inc., the company that licensed its formulation, intellectual properties, and other technologies to BioAdaptives, Inc. and its financial supporter. “Mr. …

BioAdaptives Prepares For The Next Step Read More »

Scroll to Top